Translating Inhaled and Nasal Technologies
Please join us for this free, live Ask the Expert webcast.
for the Delivery of Biologics
Just fill out the form below to register.
Mark has nearly 20 years’ experience working within the pharmaceutical analysis and formulation development industry, with a particular focus on orally inhaled and nasal drug products (OINDPs). Mostly working in the preapproval stages, Mark’s background includes extensive experience with product and formulation development for novel and generic products as well as method development and validation, stability studies, pharmaceutical development activities, and clinical-trial manufacturing for a wide range of clients.